Drugs / Rg3
last change Dec 2015 re-read 3 minutes ago

Rg3

Developed for
hepatocellular carcinoma
Investigated by
Eastern Hepatobiliary Surgery Hospital

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02724358 Dec 2012 → Dec 2013 hepatocellular carcinoma Eastern Hepatobiliary Surgery Hospital Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Rg3 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02724358 ↗